Data Collective IV’s Definium Therapeutics DFTX Stock Holding History

Data Collective IV’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9M	Hold	100,350	–	–	3.39%	4
2025 Q4	$1.34M	Hold	100,350	–	–	2.3%	3
2025 Q3	$1.18M	Hold	100,350	–	–	1.74%	3
2025 Q2	$651K	Hold	100,350	–	–	0.5%	4
2025 Q1	$587K	Hold	100,350	–	–	0.68%	4
2024 Q4	$698K	Hold	100,350	–	–	0.31%	5
2024 Q3	$571K	Hold	100,350	–	–	0.35%	5
2024 Q2	$724K	Hold	100,350	–	–	0.51%	5
2024 Q1	$943K	Hold	100,350	–	–	0.82%	4
2023 Q4	$367K	Buy	100,350 +1	+0%	+$3	0.3%	4
2023 Q3	$314K	Sell	100,349 -1	-0%	-$4	0.3%	4
2023 Q2	$358K	Hold	100,350	–	–	0.27%	5
2023 Q1	$318K	Hold	100,350	–	–	0.34%	5
2022 Q4	$221K	Sell	100,350 -1,404,898	-93%	-$3.9M	0.23%	5
2022 Q3	$5.22M	Buy	1,505,248 +1,404,898	+1,400%	+$13.5M	4.13%	5
2022 Q2	$1.23M	Hold	100,350	–	–	1.02%	5
2022 Q1	$1.67M	Hold	100,350	–	–	0.35%	5
2021 Q4	$2.6M	Buy	+100,350	New	+$3.2M	0.35%	5

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Data Collective IV's DFTX Position: Q1 2026 in Review

Data Collective IV held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 100,350 shares worth $1.9M. The position accounts for 3.39% of the portfolio, ranked #4.

Data Collective IV first reported a position in DFTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.22M in Q3 2022. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Data Collective IV held 100,350 shares of Definium Therapeutics worth $1.9M as of Q1 2026.
Data Collective IV left its Definium Therapeutics share count unchanged in Q1 2026.
Definium Therapeutics made up 3.39% of Data Collective IV's portfolio in Q1 2026, its #4 holding.
Data Collective IV first reported a position in Definium Therapeutics in Q4 2021 and has held it in 18 quarters since.
Data Collective IV's Definium Therapeutics position peaked at $5.22M in Q3 2022.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Data Collective IV's 13F filing for Q1 2026, filed 15 May 2026.